71 related articles for article (PubMed ID: 25583782)
21. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes.
Woerner SM; Benner A; Sutter C; Schiller M; Yuan YP; Keller G; Bork P; Doeberitz Mv; Gebert JF
Oncogene; 2003 Apr; 22(15):2226-35. PubMed ID: 12700659
[TBL] [Abstract][Full Text] [Related]
22. The potential of targeting Wnt/β-catenin in colon cancer.
Sebio A; Kahn M; Lenz HJ
Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
[TBL] [Abstract][Full Text] [Related]
23. Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.
Song S; Christova T; Perusini S; Alizadeh S; Bao RY; Miller BW; Hurren R; Jitkova Y; Gronda M; Isaac M; Joseph B; Subramaniam R; Aman A; Chau A; Hogge DE; Weir SJ; Kasper J; Schimmer AD; Al-awar R; Wrana JL; Attisano L
Cancer Res; 2011 Dec; 71(24):7628-39. PubMed ID: 22009536
[TBL] [Abstract][Full Text] [Related]
24. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.
Froggatt NJ; Green J; Brassett C; Evans DG; Bishop DT; Kolodner R; Maher ER
J Med Genet; 1999 Feb; 36(2):97-102. PubMed ID: 10051005
[TBL] [Abstract][Full Text] [Related]
25. Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability.
Piao Z; Fang W; Malkhosyan S; Kim H; Horii A; Perucho M; Huang S
Cancer Res; 2000 Sep; 60(17):4701-4. PubMed ID: 10987271
[TBL] [Abstract][Full Text] [Related]
26. Targeting the mTOR/4E-BP pathway in endometrial cancer.
Korets SB; Czok S; Blank SV; Curtin JP; Schneider RJ
Clin Cancer Res; 2011 Dec; 17(24):7518-28. PubMed ID: 22142830
[TBL] [Abstract][Full Text] [Related]
27. MSI-low, a real phenomenon which varies in frequency among cancer types.
Halford SE; Sawyer EJ; Lambros MB; Gorman P; Macdonald ND; Talbot IC; Foulkes WD; Gillett CE; Barnes DM; Akslen LA; Lee K; Jacobs IJ; Hanby AM; Ganesan TS; Salvesen HB; Bodmer WF; Tomlinson IP; Roylance RR
J Pathol; 2003 Nov; 201(3):389-94. PubMed ID: 14595750
[TBL] [Abstract][Full Text] [Related]
28. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum.
Ouyang H; Shiwaku HO; Hagiwara H; Miura K; Abe T; Kato Y; Ohtani H; Shiiba K; Souza RF; Meltzer SJ; Horii A
Cancer Res; 1997 May; 57(10):1851-4. PubMed ID: 9157973
[TBL] [Abstract][Full Text] [Related]
29. Targeting PI3K signaling as a therapeutic approach for colorectal cancer.
Zhang J; Roberts TM; Shivdasani RA
Gastroenterology; 2011 Jul; 141(1):50-61. PubMed ID: 21723986
[TBL] [Abstract][Full Text] [Related]
30. Targeting molecular pathways in endometrial cancer: a focus on the FGFR pathway.
Lee PS; Secord AA
Cancer Treat Rev; 2014 May; 40(4):507-12. PubMed ID: 24332498
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability.
Albuquerque C; Baltazar C; Filipe B; Penha F; Pereira T; Smits R; Cravo M; Lage P; Fidalgo P; Claro I; Rodrigues P; Veiga I; Ramos JS; Fonseca I; Leitão CN; Fodde R
Genes Chromosomes Cancer; 2010 Aug; 49(8):746-59. PubMed ID: 20544848
[TBL] [Abstract][Full Text] [Related]
32. Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease.
Taylor N; Mutch DG
Oncology (Williston Park); 2006 Jan; 20(1):85-94; discussion 94-6, 100. PubMed ID: 16572595
[TBL] [Abstract][Full Text] [Related]
33. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
Lipton LR; Johnson V; Cummings C; Fisher S; Risby P; Eftekhar Sadat AT; Cranston T; Izatt L; Sasieni P; Hodgson SV; Thomas HJ; Tomlinson IP
J Clin Oncol; 2004 Dec; 22(24):4934-43. PubMed ID: 15611508
[TBL] [Abstract][Full Text] [Related]
34. Target gene mutation profile differs between gastrointestinal and endometrial tumors with mismatch repair deficiency.
Duval A; Reperant M; Compoint A; Seruca R; Ranzani GN; Iacopetta B; Hamelin R
Cancer Res; 2002 Mar; 62(6):1609-12. PubMed ID: 11912129
[TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer and genetic alterations in the Wnt pathway.
Segditsas S; Tomlinson I
Oncogene; 2006 Dec; 25(57):7531-7. PubMed ID: 17143297
[TBL] [Abstract][Full Text] [Related]
36. [New insights into molecular target therapy for colorectal cancer].
Kanemitsu K; Yamashita K; Sumi Y; Suzuki S; Tanaka K; Kakeji Y
Nihon Shokakibyo Gakkai Zasshi; 2012 Dec; 109(12):2021-30. PubMed ID: 23221050
[No Abstract] [Full Text] [Related]
37. Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis.
Dal Molin M; Zhang M; de Wilde RF; Ottenhof NA; Rezaee N; Wolfgang CL; Blackford A; Vogelstein B; Kinzler KW; Papadopoulos N; Hruban RH; Maitra A; Wood LD
Clin Cancer Res; 2015 Apr; 21(8):1944-50. PubMed ID: 25623214
[TBL] [Abstract][Full Text] [Related]
38. Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling.
Tsukiyama T; Fukui A; Terai S; Fujioka Y; Shinada K; Takahashi H; Yamaguchi TP; Ohba Y; Hatakeyama S
Mol Cell Biol; 2015 Jun; 35(11):2007-23. PubMed ID: 25825523
[TBL] [Abstract][Full Text] [Related]
39. A pathway-centric survey of somatic mutations in Chinese patients with colorectal carcinomas.
Ling C; Wang L; Wang Z; Xu L; Sun L; Yang H; Li WD; Wang K
PLoS One; 2015; 10(1):e0116753. PubMed ID: 25617745
[TBL] [Abstract][Full Text] [Related]
40. Genetics of Opisthorchis viverrini-related cholangiocarcinoma.
Jusakul A; Kongpetch S; Teh BT
Curr Opin Gastroenterol; 2015 May; 31(3):258-63. PubMed ID: 25693006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]